In vitro and in vivo delivery of gliclazide loaded mPEG-PCL micelles and its kinetic release and solubility study
Source abstract
Abstract
In this study, drug delivery system of gliclazide, a poorly soluble drug, was developed and evaluated in vitro and in vivo. We synthesized five series of mPEG-PCL di block copolymers. The structure of the copolymers was characterized by 1H-NMR, Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC) and gel permeation chromatography (GPC) techniques. In this study, gliclazide was encapsulated within micelles through a single-step nano-precipitation method, leading to formation of gliclazide/mPEG-PCL micelles. The resulting micelles were characterized further by various techniques such as DLS and AFM. The serum glucose lowering effect of gliclazide micelles was studied in streptozotocin-diabetic rats and were compared with the gliclazide treated rats. The results showed that the zeta potential of micelles was about −14.9 mV and the average size was 83.12 nm. Gliclazide was encapsulated into mPEG-PCL micelles with loading capacity of 21.05 ± 0.14% and entrapment efficiency of 94.11 ± 0.12%. In vivo testing of the gliclazide micelles in diabetic rats demonstrated a significant antidiabetic effect of gliclazide micelles after the 7 day that lasted for 21 days when compared with gliclazide powder. The results suggest that gliclazide micelles are a valuable system for the sustained delivery of gliclazide.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Surfactants and Colloidal Systems · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran;
Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran;
Department of Pharmacology and Toxicology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran
Funding
Zanjan University of Medical Sciences
References (33)
Show source-provided references
1. 10.1016/S0026-0495(03)00215-410.1016/S0026-0495(03)00215-4 ↗
2. 10.1007/BF0040063210.1007/BF00400632 ↗
3. Cabral H, Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release. 2014;190:465–476.10.1016/j.jconrel.2014.06.042 ↗
4. 10.1016/j.nutres.2006.12.00810.1016/j.nutres.2006.12.008 ↗
5. 10.1016/0168-8227(91)90005-X10.1016/0168-8227(91)90005-X ↗
6. Sarker A · J Appl Pharma Sci · 2011 · 1 · 11
7. 10.1016/1056-8727(94)90044-210.1016/1056-8727(94)90044-2 ↗
8. 10.2165/00003495-199346010-0000710.2165/00003495-199346010-00007 ↗
9. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed. 2007;18:241–268.10.1163/156856207779996931 ↗
10. 10.1080/21691401.2017.128250110.1080/21691401.2017.1282501 ↗
11. 10.1016/j.ijpharm.2009.07.03310.1016/j.ijpharm.2009.07.033 ↗
12. 10.1136/pgmj.2004.02839910.1136/pgmj.2004.028399 ↗
13. Poorbarkhordari E, Fooladsaz K, Hosseini SH, et al. The hypoglycemic effects of an ethanol extract of Peganum harmala in streptozotocin-induced diabetic rats. Iran J Pharm Res. 2014;10:47–54.
14. 10.1016/j.polymer.2007.09.02110.1016/j.polymer.2007.09.021 ↗
15. Yodthong B. · J Appl Sci · 2009 · 9 · 2278
16. 10.1055/s-0042-11093110.1055/s-0042-110931 ↗
17. 10.1088/0957-4484/23/30/30530210.1088/0957-4484/23/30/305302 ↗
18. 10.1177/088532821769806310.1177/0885328217698063 ↗
19. 10.2174/13894501179590664210.2174/138945011795906642 ↗
20. Danafar H, Rostamizadeh K, Davaran S, et al. Drug-conjugated PLA–PEG–PLA copolymers: a novel approach for controlled delivery of hydrophilic drugs by micelle formation. Pharm Dev Technol. 2017;22:947–957.10.3109/10837450.2015.1125920 ↗
21. 10.1016/j.jconrel.2004.11.01810.1016/j.jconrel.2004.11.018 ↗
22. 10.1055/s-0043-10605110.1055/s-0043-106051 ↗
23. 10.1080/21691401.2017.134788010.1080/21691401.2017.1347880 ↗
24. 10.15171/PS.2016.3710.15171/PS.2016.37 ↗
25. Zijah V, Salehi R, Aghazadeh M, et al. Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line. Artif Cells Nanomed Biotechnol. 2017;45:432–440.10.3109/21691401.2016.1160915 ↗
26. Asghari F, Samiei M, Adibkia K, et al. Biodegradable and biocompatible polymers for tissue engineering application: a review. Artif Cells Nanomed Biotechnol. 2017;45:185–192.10.3109/21691401.2016.1146731 ↗
27. 10.1055/s-0042-10986510.1055/s-0042-109865 ↗
28. Lin SY · Pharm Acta Helv · 1985 · 60 · n339
29. Danafar H. · Jundishapur J Nat Pharm Prod · 2017 · 12 · e34179
30. 10.15171/PS.2015.3210.15171/PS.2015.32 ↗
31. 10.1016/j.addr.2003.12.00410.1016/j.addr.2003.12.004 ↗
32. 10.1002/pola.2700910.1002/pola.27009 ↗
33. Danafar H, Rostamizadeh K, Davaran S, et al. Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG-PCL nanoparticles. Drug Dev Ind Pharm. 2017;43:1908–1918.10.1080/03639045.2017.1355922 ↗